• LAST PRICE
    0.2000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.1800/ 50
  • Ask / Lots
    0.4712/ 25
  • Open / Previous Close
    0.0000 / 0.2000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0621
    High 0.3300
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.181
TimeVolumeNSTM
02:22 ET1000.2
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNSTM
Novelstem International Corp
9.4M
0.7x
---
United StatesHALB
Halberd Corp
9.2M
7.0x
---
United StatesIMNN
Imunon Inc
10.0M
-0.3x
---
United StatesPSTV
Plus Therapeutics Inc
9.7M
-0.3x
---
United StatesMYMX
Mymetics Corp
7.9M
-1.4x
---
United StatesNAVB
Navidea Biopharmaceuticals Inc
9.4M
-0.5x
---
As of 2023-03-28

Company Information

NovelStem International Corp. is focused on providing stem cell-based technology platform. The Company’s NewStem Software Diagnostic Device (NSDD) is a bioinformatics-based software medical device platform that provides oncologists with information regarding the presence of mutations in tumors, which may confer patient resistance to certain anti-cancer drugs. The Company’s diagnostic technology predicts patients’ anti-cancer drug resistance, which allows targeted cancer treatments and the potential to reduce resistance to chemotherapy. The Company’s technology is also being used for genetic research related to other medical therapies.

Contact Information

Headquarters
2255 Glades Rd, Ste 237 WBOCA RATON, FL, United States 33431
Phone
561-998-8000
Fax
561-998-2974

Executives

Executive Chairman of the Board, Chief Executive Officer, President
Jan Loeb
Chief Financial Officer, Vice President, Secretary
Christine Jenkins
Director
Tracy Clifford
Director
Eric Richman
Director
Mitchell Rubenstein

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$9.4M
Revenue (TTM)
$424.8K
Shares Outstanding
46.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.52
EPS
$0.28
Book Value
$1.34
P/E Ratio
0.7x
Price/Sales (TTM)
22.1
Price/Cash Flow (TTM)
1.5x
Operating Margin
-1,150.64%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.